15 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
injury or are found to be otherwise unsuitable during clinical trials, manufacturing, marketing or sale. Any such product liability claims could … , if approved;
decreased demand for our products;
injury to our reputation;
withdrawal of clinical trial participants and inability to continue
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp
1 Sep 23
Quarterly report
4:39pm
or are perceived to cause injury or are found to be otherwise unsuitable during clinical trials, manufacturing, marketing or sale. Any such product liability … to the market, if approved;
decreased demand for our products;
injury to our reputation;
withdrawal of clinical trial participants and inability
424B4
TSBX
Turnstone Biologics Corp
21 Jul 23
Prospectus supplement with pricing info
7:14pm
. For example, we may be sued if our product candidates cause or are perceived to cause injury or are found to be otherwise unsuitable during clinical trials … , liability claims may result in:
inability to bring a product candidate to the market, if approved;
decreased demand for our products;
injury to our
S-1/A
pregt
23 Jun 23
IPO registration (amended)
9:49pm
S-1
EX-10.9
v0loncv3prux ufjkm
12 Jun 23
IPO registration
4:28pm
S-1
4vjwac9w
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.8
fdeas4uetxwi
12 Jun 23
IPO registration
4:28pm
S-1
EX-2.1
jrvj191yf9v
12 Jun 23
IPO registration
4:28pm
DRS
EX-2.1
2yoh3x q4dym
15 May 23
Draft registration statement
12:00am
DRS
EX-10.9
e24eb7cfbrlfx9juaap
15 May 23
Draft registration statement
12:00am
DRS
EX-10.8
l1stxi2n
15 May 23
Draft registration statement
12:00am
DRS
av2p4g yu55
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next